Is a
Clinical Study attributes
NCT Number
Health Conditions in Trial
Trial Recruitment Size
330
Trial Sponsor
Clinical Trial Start Date
2015
0Primary Completion Date
2016
0Study Completion Date
2016
0Clinical Trial Study Type
Interventional0
Interventional Trial Purpose
Other0
Intervention Type
Drug0
Intervention Name
Acetaminophen0
Warfarin0
Lisinopril0
ITCA 650 20/60 mcg/day0
Digoxin0
Atorvastatin0
Interventional Trial Phase
Phase 10
Official Name
A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate the Effects of ITCA 650 on Gastric Emptying and on the Absorption Pharmacokinetics of Each of 4 Commonly Studied Drug/Drug Interaction (DDI) Probe Compounds0
Last Updated
January 27, 2017
0Allocation Type
NA0
Intervention Model
Single Group Assignment0
Masking Type
None (Open Label)0
Study summary
A Phase 1, Fixed-Sequence, Open-label Study in Healthy Subjects to Estimate the Effects of ITCA 650 on Gastric Emptying and on the Absorption Pharmacokinetics of Each of 4 Commonly Studied DDI Probe Compounds.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
